Co-Diagnostics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CODX, updated each market day.
CODX AI Sentiment
AI sees no strong directional signal for Co-Diagnostics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Co-Diagnostics, Inc. Common Stock
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Sector
Exchange
Market Cap
$6,160,215
Cap Tier
Employees
115
Headquarters
SALT LAKE CITY, UT
Listed Since
July 12, 2017
Website
CODX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CODX Volatility
Co-Diagnostics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
